Minimal residual disease (MRD) assessment by flow cytometry after ASCT for AL amyloidosis: are we there yet?

Lee H.; Duggan P.; Neri P.; Tay J.; Bahlis N. J.; Jimenez-Zepeda V. H.

首页> 外文期刊>Bone marrow transplantation >Minimal residual disease (MRD) assessment by flow cytometry after ASCT for AL amyloidosis: are we there yet?

【24h】

Minimal residual disease (MRD) assessment by flow cytometry after ASCT for AL amyloidosis: are we there yet?

机译：通过流式细胞术后的最小残留疾病（MRD）评估ASCT以ASCT用于ASC淀粉样症：我们是否存在？

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Bone marrow transplantation》 |2017年第6期|共3页
作者
Lee H.; Duggan P.; Neri P.; Tay J.; Bahlis N. J.; Jimenez-Zepeda V. H.;
展开▼
作者单位

Tom Baker Canc Clin Dept Med Oncol &

Hematol Calgary AB Canada;

Tom Baker Canc Clin Dept Med Oncol &

Hematol Calgary AB Canada;

Tom Baker Canc Clin Dept Med Oncol &

Hematol Calgary AB Canada;

Tom Baker Canc Clin Dept Med Oncol &

Hematol Calgary AB Canada;

Tom Baker Canc Clin Dept Med Oncol &

Hematol Calgary AB Canada;

Tom Baker Canc Clin Dept Med Oncol &

Hematol Calgary AB Canada;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类治疗学;
关键词

相似文献

外文文献
中文文献
专利

1. Minimal residual disease (MRD) assessment by flow cytometry after ASCT for AL amyloidosis: are we there yet? [J] . Lee H., Duggan P., Neri P., Bone marrow transplantation . 2017,第6期

机译：通过流式细胞术后的最小残留疾病（MRD）评估ASCT用于ASCAl淀粉样症：我们是否存在？
2. Minimal residual disease (MRD) assessment by flow cytometry after ASCT for AL amyloidosis: are we there yet? [J] . Lee H., Duggan P., Neri P., Bone marrow transplantation . 2017,第6期

机译：通过流式细胞术后的最小残留疾病（MRD）评估ASCT以ASCT用于ASC淀粉样症：我们是否存在？
3. Minimal Residual Disease (MRD) Detection By Flow Cytometry Complements Molecular MRD Assessment in AML [J] . Buecklein Veit, Koehnke Thomas, Schnorfeil Frauke, Blood: The Journal of the American Society of Hematology . 2018,第NovaelaTreatmentAppr期

机译：通过流式细胞仪检测最小的残余疾病（MRD）检测在AML中补充分子MRD评估
4. Measuring Minimal Residual Disease in Multiple Myeloma by LC-MS/MS; A Comparison to Multicolor Flow Cytometry [C] . H. Robert Bergen, Angela Dispenzieri, Surendra Dasari, ASMS Conference on Mass Spectrometry and Allied Topics . 2015

机译：通过LC-MS / MS测量多发性骨髓瘤中的最小残留疾病;与多色流式细胞术的比较
5. Detection and Monitoring of Multiple Myeloma Measurable Residual Disease by High Sensitivity Flow Cytometry [D] . Soh, Kah Teong. 2020

机译：高灵敏度流式细胞术检测和监测多发性骨髓瘤可测量的残留疾病
6. Assessment of minimal residual disease using multiparametric flow cytometry in patients with AL amyloidosis [O] . Andrew Staron, Eric J. Burks, John C. Lee, 2020

机译：使用多参数流式细胞术评估AL淀粉样变性患者的最小残留病
7. Longitudinal Flow Cytometry Identified “Minimal Residual Disease” (MRD) Evolution Patterns for Predicting the Prognosis of Patients with Transplant-Eligible Multiple Myeloma [O] . Jingli Gu, Junru Liu, Meilan Chen, 2018

机译：纵向流式细胞仪鉴定了“最小的残留疾病”（MRD）演化模式，用于预测移植符合符合条件多发性骨髓瘤患者的预后

Minimal residual disease (MRD) assessment by flow cytometry after ASCT for AL amyloidosis: are we there yet?

著录项

相似文献

相关主题

期刊订阅